M4MM
MariMed Reports Q4 and FY 2025 Financial Results
NORWOOD – MariMed Inc. released its fourth-quarter and full-year 2025 financial results, reporting a modest revenue increase that reflects the company’s focus on branded wholesale gains in an environment of sustained margin compression across multiple ...
Verano Reports Q4 and FY 2025 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the fourth quarter and full year ended December 31, 2025, showing sequential revenue growth and improved gross margins in the final three months but a ...
Cannabinoids and Fatty Liver Disease: Emerging Research Highlights a Growing Health Challenge for Seniors
LOS ANGELES- A growing body of scientific research is examining how compounds derived from Cannabis may interact with metabolic diseases that affect hundreds of millions of people worldwide. Among the most widespread of these conditions is ...
Opinion: The Timing Has Never Been Better for Industrial Hemp
LOS ANGELES- A few years ago, ‘sustainable’ was a buzzword. Using the word ‘sustainable’ in marketing messages was a clever way for a company or brand appear to be living in the now, without having ...
Malta Raises Stock Limits for Cannabis Associations
VALLETTA – Maltese regulators have raised the amounts of Cannabis that non-profit associations can keep on hand, responding to supply challenges faced by the country's Cannabis clubs. The updates, introduced through a legal notice, replace ...
California Cannabis Awards 2026 Opens Submission Window for Its Fifth Edition
SACRAMENTO – Organizers of the California Cannabis Awards have announced they are accepting entries for the 2026 competition. This will be the 5th edition of the state-sanctioned program that recognizes quality across licensed Cannabis products, ...
Prohibition Partners Released Poland Medical Cannabis Market Review
WARSAW – Prohibition Partners has published its Poland Medical Cannabis Market Review 2026, a detailed examination of pharmacy-level sales data through the full year 2025 along with projections for 2026 and 2027. The report, prepared ...
MariMed Reports Q4 and FY 2025 Financial Results
NORWOOD – MariMed Inc. released its fourth-quarter and full-year 2025 financial results, reporting a modest revenue increase that reflects the company’s focus on branded wholesale gains in an environment of sustained margin compression across multiple ...
Verano Reports Q4 and FY 2025 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the fourth quarter and full year ended December 31, 2025, showing sequential revenue growth and improved gross margins in the final three months but a ...
Cannabinoids and Fatty Liver Disease: Emerging Research Highlights a Growing Health Challenge for Seniors
LOS ANGELES- A growing body of scientific research is examining how compounds derived from Cannabis may interact with metabolic diseases that affect hundreds of millions of people worldwide. Among the most widespread of these conditions is ...
Rubicon Organics Reports Q2 2025 Financial Results
VANCOUVER, BC – Rubicon Organics Inc., a leading Canadian producer of premium organic Cannabis, announced financial results for the second quarter ending June 30, 2025. The company reported net revenue of $15 million, a 24% ...
Week In Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Lively discussions were fueled last week by policy developments, financial reports, and strategic expansions in the Cannabis and Psychedelics industries. From federal rescheduling debates to global market moves, the Highly Capitalized Network ...
A LIFE IN A DAY: David Peck, CEO of Headquarters
LOS ANGELES- In this edition of A LIFE IN A DAY, Highly Capitalized Network catches up with David Peck, the founder and CEO of Headquarters (HQ)—an operations partner for Cannabis businesses across the country. Headquarters ...
Glass House Brands Reports Q2 2025 Financial Results
LONG BEACH and TORONTO – Glass House Brands Inc., a leading vertically integrated Cannabis operator in the US, unveiled its second-quarter 2025 financial statements, showing impressive growth in key areas despite ongoing market pressures and ...
Psychedelics Market Set to Reach $22.6 Billion by 2033, Report Finds
NEW YORK – A recent report by Research and Markets reveals the current global psychedelic drugs market is valued at $7.4 billion and is projected to hit $22.6 billion by 2033, exhibiting a substantial compound ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Cresco Labs Strengthens Financial Position with $325 Million Senior Secured Term Loan Refinancing
CHICAGO – Cresco Labs Inc. announced the closing of a significant refinancing transaction, marking a strategic move towards long-term balance sheet stability. The company successfully replaced its previous $360 million senior secured credit facility with ...
Planet 13 Reports Q2 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a vertically integrated multi-state Cannabis operator, released its Q2 2025 financial results, reflecting a challenging quarter marked by market pressures and strategic adjustments. The company reported revenue of ...
Organigram Reports Q3 FY2025 Financial Results
TORONTO – Organigram Global Inc. announced record financial results for its third quarter of fiscal 2025, ending June 30, 2025. The company achieved significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and ...
Cannabis MSOs Face High-Stakes Tax Dilemma as Rescheduling Decision Looms Under Trump
As Trump's administration weighs reclassifying Cannabis to Schedule III, Cannabis giants continue to contend with hefty uncertain tax liabilities under IRS Section 280E, a rule that has long hampered their financial flexibility. A recent report ...
Grown Rogue Reports Q2 2025 Financial Results
MEDFORD – Grown Rogue International Inc., a flower-focused Cannabis producer known for its craft-driven approach and scaled operations, reported its second quarter 2025 financial results for the period ending June 30, 2025. The company delivered ...
Is This a Meltdown For Michigan Cannabis Market?
LANSING – Michigan's legal Cannabis industry, once a hot spot for progress since recreational legalization in 2018, is now struggling with some serious financial pressures that could threaten its stability. According to a recent report ...
Cannabis Stocks Show Sensitivity to Q2 2025 Earnings Despite Market Volatility
LOS ANGELES – In the Cannabis industry, where trading often revolves around speculation and regulatory rumors, a recent analysis suggests that core financial performance still influences investor behavior. According to a recent report from Viridian ...
NYC Near-School Cannabis Dispensaries Avoid Shutdown or Relocation
NEW YORK – A significant number of New York’s licensed Cannabis dispensaries, previously at risk of closure for being too close to schools, have received a lifeline from state regulators. The Office of Cannabis Management ...
